Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Story1
Group 1 Automotive gives Conifer a board seat and caps its stake at 19% under new stockholder agreement
SEC filings show Group 1 Automotive will expand its board to 11 and appoint a Conifer Management analyst from 1 November, in return for standstill and voting commitments from Conifer.
Company or person3
Family Trading Inc.
Company
Trade Desk, Inc.
Company
Fastly, Inc.
Company
Primary record20
UR-ENERGY INC filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 28, 2026, Roger L. Smith, the Chief Financial Offi
Syndax Pharmaceuticals Inc filed 8-K
Item 2.02. Results of Operations and Financial Condition. On November 2, 2026, Syndax Pharmaceuticals, Inc. (the “ Company ”) issued a press release and presentation announcing its financial results for the quarter ended
Family Trading Inc. filed SCHEDULE 13D/A
(the "Commission") by Mr. Evangelos J. Pistiolis, Family Trading Inc. ("Family Trading") and 3 Sororibus Trust (the "Trust") on September 24, 2026 (as previously amended and supplemented, the "Schedule 13D"). This Amendm
Shutterstock, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. CEO Appointment On October 28, 2026, the Board of Directors (th
MONOLITHIC POWER SYSTEMS, INC. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On October 29, 2026, Monolithic Power Systems, Inc. (the “Company”) issued a press release regarding its financial results for the quarter ended September 30, 2026
Strategy Inc filed 8-K
Item 2.02. Results of Operations and Financial Condition. On October 29, 2026, Strategy Inc (the “Company”) issued a press release announcing the Company’s financial results for the quarter ended September 30, 2026. A co
Nextpower Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On October 28, 2026, Nextpower Inc. (the “Company”) issued a press release announcing its results for the second fiscal quarter ended October 2, 2026. A copy of th
Arcutis Biotherapeutics, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 23, 2026, the Board of Directors (the “Board”) of Ar
TrueBlue, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 26, 2026, TrueBlue, Inc. (the “Company”) announced
Churchill Capital Corp XIII filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of New Director On October 23, 2026, the board of
AMASS BRANDS filed 8-K
Item 3.03 Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K is incorporated by reference into
Global Interactive Technologies, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. On October 15, 2026, the Board of Directors (the “Board”) of Glo
FARMHOUSE, INC. /NV filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers On October 12, 2026, the Board of Directors (the “Board”) of Far
Change Agents Corporation. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 14, 2026, Change Agents Corporation (the “Company”)
Datavault AI Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of Director On October 11, 2026, Wendy Wilson tende
LISATA THERAPEUTICS, INC. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) On October 13, 2026, upon the recommendation of the Nominat
Harmony Biosciences Holdings, Inc. filed 8-K
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of President and Chief Executive Officer and Directo
Melco International Development LTD filed SCHEDULE 13D/A
0001193125-26-418399.txt : 20261009 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0001389153 XXXXXXXX LIVE 10 Ordinary Shares, par value $0.01 per share 10/09/2026 false 0001381640 585464100 Melco Resorts & Enter
GOLDENWELL BIOTECH, INC. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 8, 2026, the board of directors of Goldenwell Biotec
T3 Defense Inc. filed 8-K
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers . On October 7, 2026, the Board of Directors (the Board ) of T3 Defense Inc., a Delaware corporation (the